Listeria Clinical Trials This is an RSS file. You can use it to subscribe to this data in your favourite RSS reader or to display this data on your own website or blog.

• News
• Research
• Blogs
• Podcasts
• Video
• Funding
• Alerts
• Clinical Trials
• Forums

Safety & Immunogenicity of JNJ-64041809, a Live Attenuated Double-deleted Listeria Immunotherapy, in Participants With Metastatic Castration-resistant Prostate Cancer
Condition:   Prostatic Neoplasms, Castration-ResistantInterventions:   Biological: JNJ-64041809 (Cohort 1A and 1B);   Biological: JNJ-64041809 (Cohort 2A and 2B)Sponsor:   Janssen Research & Development, LLCNot yet recruiting - verified December 2015 (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - December 7, 2015 Category: Research Source Type: clinical trials

Safety & Immunogenicity of JNJ-64041757, Live-attenuated Double-deleted Listeria Immunotherapy, in Subjects With Non Small Cell Lung Cancer
Condition:   Carcinoma, Non-Small-Cell LungIntervention:   Biological: JNJ-64041757Sponsor:   Janssen Research & Development, LLCNot yet recruiting - verified October 2015 (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - October 29, 2015 Category: Research Source Type: clinical trials